Strong Expression of P53 Protein in Bone Marrow after Hematopoietic Stem Cell Transplantation Indicates Risk of Relapse in Pediatric Acute Lymphoblastic Leukemia Patients

MLA

Kristin Mattsson, et al. “Strong Expression of P53 Protein in Bone Marrow after Hematopoietic Stem Cell Transplantation Indicates Risk of Relapse in Pediatric Acute Lymphoblastic Leukemia Patients.” Biology of Blood and Marrow Transplantation, vol. 24, Mar. 2018, p. S299. EBSCOhost, https://doi.org/10.1016/j.bbmt.2017.12.341.

APA

Kristin Mattsson, Gisela Barbany, Emma Honkaniemi, Britt Gustafsson, & Birgitta Sander. (2018). Strong Expression of P53 Protein in Bone Marrow after Hematopoietic Stem Cell Transplantation Indicates Risk of Relapse in Pediatric Acute Lymphoblastic Leukemia Patients. Biology of Blood and Marrow Transplantation, 24, S299. https://doi.org/10.1016/j.bbmt.2017.12.341

Chicago

Kristin Mattsson, Gisela Barbany, Emma Honkaniemi, Britt Gustafsson, and Birgitta Sander. 2018. “Strong Expression of P53 Protein in Bone Marrow after Hematopoietic Stem Cell Transplantation Indicates Risk of Relapse in Pediatric Acute Lymphoblastic Leukemia Patients.” Biology of Blood and Marrow Transplantation 24 (March): S299. doi:10.1016/j.bbmt.2017.12.341.